Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday â after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets